NMPA Approval

Cefoperazone Sodium and Tazobactam Sodium for Injection(4:1)

Approval Number

国药准字H20193194

Company苏州东瑞制药有限公司

Registration Date

July 4, 2019

Drug Information

Generic Name

注射用头孢哌酮钠他唑巴坦钠(4:1)

Dosage Form

注射剂

Strength

2.0g（C25H27N9O8S2 1.6g与C10H12N4O5S 0.4g）。

Drug Type

化学药品

Registration Date

July 4, 2019

Company Information

Applicant Company

Company Name苏州东瑞制药有限公司

Company Address

江苏省苏州吴中经济开发区天灵路22号

Manufacturing Company

Company Name苏州东瑞制药有限公司

Company Address

江苏省苏州吴中经济开发区天灵路22号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用头孢哌酮钠他唑巴坦钠(4:1) - NMPA 批准文号 | MedPath